Opyl Limited (ASX:OPL)

9.5¢

right-arrow Created with Sketch. 0 (0%)
MCAP $5.166M
Last trade 14.00pm 28/01/2022 20mins delayed

Latest Announcements

09.33am 28/01/2022 Price SensitivePSOPLOpyl Limited
23/12/2021OPLOpyl Limited
15/12/2021OPLOpyl Limited
02/12/2021OPLOpyl Limited
30/11/2021OPLOpyl Limited
30/11/2021OPLOpyl Limited

Company Overview

Opyl Limited is a Australia-based company that provides biopharma and health organizations access to emerging artificial intelligence (AI)-assisted technologies and guidance to understand and improve healthcare design, development and delivery. The Company is focused on executing the change in direction into digital health, rebuilding the research and development pipeline to deliver solutions for the global health and life sciences sector. The Company has built a Opin, which is clinical trial recruitment platform that leverages social media, search engine optimization technologies and artificial intelligence science, matching patients directly to clinical trials. The Company is also developing Clinical trial prediction and protocol design tool. The Company subsidiaries include ShareRoot Inc, ShareRoot (Australian Ops) Pty Ltd, Opyl Services and Ludomade, Inc.

OPL in the news

Medical tech support company Opyl (OPL) has completed an off-market share buy-back…
Medical tech support company Opyl (OPL) has received commitments for a share…
Medical tech support company Opyl (OPL) soared today after announcing it has…

Search Previous Announcements